Filtered By:
Source: NYT Health
Infectious Disease: Coronavirus
This page shows you your search results in order of date.
Order by Relevance | Date
Total 33 results found since Jan 2013.
Hearing on Covid ’s Origins Promises Politics Mixed With Substance
In advance of a hearing on Wednesday expected to focus on the lab leak theory, House Republicans took aim at Dr. Anthony S. Fauci, whom they have long vowed to investigate.
Source: NYT Health - March 7, 2023 Category: Consumer Health News Authors: Sheryl Gay Stolberg and Benjamin Mueller Tags: Coronavirus (2019-nCoV) House of Representatives Fauci, Anthony S Andersen, Kristian G Laboratories and Scientific Equipment Espionage and Intelligence Services Research National Institute of Allergy and Infectious Diseases United States P Source Type: news
Anthony Fauci Prepares for Retirement After Half a Century in Government
The nation ’s top infectious disease expert, whose last day as a federal employee is Saturday, plans to write a memoir and wants to encourage people to go into public service.
Source: NYT Health - December 29, 2022 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Fauci, Anthony S Content Type: Personal Profile Coronavirus (2019-nCoV) Vaccination and Immunization National Institute of Allergy and Infectious Diseases United States Politics and Government Government Employees Medicine and Health Source Type: news
Four Decades of Dr. Fauci
Anthony Fauci did not set out to become a political lightning rod. But, as Sheryl Gay Stolberg explains, he couldn ’t escape becoming a polarizing figure in Donald Trump’s Washington.
Source: NYT Health - August 22, 2022 Category: Consumer Health News Tags: United States Politics and Government internal-sub-only-nl Fauci, Anthony S Trump, Donald J Coronavirus (2019-nCoV) National Institute of Allergy and Infectious Diseases Source Type: news
Fauci Says He Will Step Down in December to Pursue His ‘Next Chapter’
Dr. Anthony S. Fauci, who has advised seven presidents and spent more than half a century at the National Institutes of Health, will leave government service by the end of the year.
Source: NYT Health - August 22, 2022 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Fauci, Anthony S National Institute of Allergy and Infectious Diseases National Institutes of Health Appointments and Executive Changes Government Employees United States Politics and Government Coronavirus (2019-nCoV) Biden, Joseph R Jr T Source Type: news
Is the Coronavirus Getting Better at Airborne Transmission?
The Alpha variant traveled more efficiently in small droplets, two new studies found. The Delta variant may have continued this evolution.
Source: NYT Health - October 1, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Masks Coronavirus Delta Variant Coronavirus (2019-nCoV) Coronavirus Risks and Safety Concerns Disease Rates Vaccination and Immunization Clinical Infectious Diseases (Journal) National Institute of Allergy and Infectious Source Type: news
U.S. Health Officials Question AstraZeneca Vaccine Trial Results
According to federal officials, an independent panel of medical experts said the encouraging results announced on Monday might have relied on outdated information.
Source: NYT Health - March 24, 2021 Category: Consumer Health News Authors: Rebecca Robbins, Noah Weiland, Sharon LaFraniere and Benjamin Mueller Tags: Clinical Trials Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Vaccination and Immunization AstraZeneca PLC Food and Drug Administration National Institute of Allergy and Infectious Diseases Oxford University Source Type: news
Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Source: NYT Health - December 25, 2020 Category: Consumer Health News Authors: Katherine J. Wu Tags: Vaccination and Immunization Drugs (Pharmaceuticals) Anaphylactic Shock Coronavirus (2019-nCoV) Immune System Allergies Centers for Disease Control and Prevention Moderna Inc Pfizer Inc your-feed-healthcare Source Type: news
Covid-19: How Much Herd Immunity is Enough?
Scientists initially estimated that 60 to 70 percent of the population needed to acquire resistance to the coronavirus to banish it. Now Dr. Anthony Fauci and others are quietly shifting that number upward.
Source: NYT Health - December 24, 2020 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Coronavirus (2019-nCoV) Disease Rates Measles Vaccination and Immunization Centers for Disease Control and Prevention National Institute for Allergy and Infectious Disease (NIAID) World Health Organization Fauci, Anthony S Lipsitch, Marc Source Type: news
Pfizer ' s Covid Vaccine and Allergies: How Concerned Should You Be?
British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.
Source: NYT Health - December 11, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Risks and Safety Concerns Clinical Trials Anaphylactic Shock Allergies Food and Drug Administration Pfizer Inc your-feed-healthcare Source Type: news
Moderna Is Applying for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.
Source: NYT Health - November 30, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Research RNA (Ribonucleic Acid) Food and Drug Administration Moderna Inc National Institute of Allergy and Infectious Diseases your-feed-healthcare Source Type: news
Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.
Source: NYT Health - November 30, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Research RNA (Ribonucleic Acid) Food and Drug Administration Moderna Inc National Institute of Allergy and Infectious Diseases your-feed-healthcare Source Type: news
Remdesivir Tests for Covid Treatments Enter New Phase
A clinical trial showed that remdesivir helped hospitalized patients. Now researchers are asking whether when the drug is paired with another antiviral drug, patients will recover faster.
Source: NYT Health - August 18, 2020 Category: Consumer Health News Authors: Gina Kolata Tags: Remdesivir (Drug) Tests (Medical) Research Placebos Dexamethasone (Drug) Coronavirus (2019-nCoV) Interferon Beta (Drugs) Immune System Gilead Sciences Inc National Institute of Allergy and Infectious Diseases your-feed-healthcare Pet Source Type: news
Contact Tracing Is Failing in Many States. Here ’s Why.
Inadequate testing and protracted delays in producing results have crippled tracking and hampered efforts to contain major outbreaks.
Source: NYT Health - July 31, 2020 Category: Consumer Health News Authors: Jennifer Steinhauer and Abby Goodnough Tags: Contact Tracing (Public Health) Tests (Medical) Coronavirus (2019-nCoV) States (US) Medicine and Health Centers for Disease Control and Prevention National Institute of Allergy and Infectious Diseases Arizona Austin (Tex) California Fl Source Type: news
Moderna Coronavirus Vaccine Test in Monkeys Shows Promise
This coronavirus vaccine developed by government researchers and Moderna enabled the animals to quickly clear the infection from their lungs.
Source: NYT Health - July 29, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Vaccination and Immunization Moderna Inc Clinical Trials Tests (Medical) Research Monkeys and Apes National Institute of Allergy and Infectious Diseases New England Journal of Medicine Vaccine (Journal) your-feed-healthcare Coronavirus Source Type: news
Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
Source: NYT Health - July 28, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Clinical Trials Vaccination and Immunization Public-Private Sector Cooperation Coronavirus (2019-nCoV) RNA (Ribonucleic Acid) Immune System Research Moderna Inc National Institute of Allergy and Infectious Diseases Pfizer Inc National Source Type: news
